A vaccine from China, namely Sinovac, which comes from Beijing, has been prepared by Brazil because

Brazil is badly affected by the corona virus. Sinovac in brazil has been found to be 50.4% effective in
Brazilian clinical trials.

Vaccines work using weakened viral particles to respond to the body's immune system.

Previously last week the Butantant Institute released a Sinovac vaccine that was 78% effective in
preventing mild cases that needed treatment, and 100% effective in preventing moderate to serious
case.

With the data that has been presented, the current level of efficacy of the synovac vaccine in brazil
between reading and listening is 50.4% and the research from the butantan institute, sinovac vaccine 78
precent effective in preventing and progress against covid.